Sclerosis News and Research

RSS

Tryptophan metabolites play an important role in the immune system

Tryptophan is the source of Thanksgiving legend and grist for a "Seinfeld" episode, but it's not the chemical that you'd expect to find in Lawrence Steinman's lab.

7 Nov 2005

Exercise is good for multiple sclerosis, but it must be done correctly

Aerobic exercise is thought to help persons with multiple sclerosis fight fatigue, the most common symptom of the disease. Yet MS also appears to cause the body to heat up more quickly, compromising the ability to exercise.

3 Nov 2005

Withdrawn MS drug works for Crohn's sufferers

Researchers say that a multiple sclerosis drug that was withdrawn from the market for safety reasons, has shown some effectiveness against the painful bowel disorder Crohn's disease.

3 Nov 2005

Gene involved in B-cell development might play a role in multiple sclerosis

The results of a large study published today in the open access journal BMC Neurology reveal that multiple sclerosis (MS) patients are more likely to carry two specific genetic variations in the Early B-cell factor gene (EBF-1), than healthy individuals.

30 Oct 2005

Trigger discovered that causes stem cells embryos to start developing into organs

They have apparently discovered the chemical trigger that causes stem cells from embryos to start developing into organs, raising the possibility of parts of the body being able to repair their own damage.

30 Oct 2005

Northwestern University move closer to new therapies for neurodegenerative disease

French neurologist Jean-Martin Charcot first described amyotrophic lateral sclerosis (ALS) in 1869, but, nearly 140 years later, little is known about the cause of the devastating neurodegenerative disease, and there is no cure.

27 Oct 2005

Intravenous lidocaine and oral derivatives relieve pain from damage to the nervous system

Lidocaine and similar local anesthetics are effective for treating pain that emanates from damaged nerves, according to a systematic review of current evidence.

23 Oct 2005

Blocking macrophage migration inhibitory factor molecule might prevent the progression of multiple sclerosis

A new study suggests that a substance made by immune cells plays a key role in the progression of a disease in animals that closely mimics multiple sclerosis (MS). The findings further suggest that blocking the molecule, known as macrophage migration inhibitory factor (MIF) might prevent the progression of the disease.

19 Oct 2005

Cannabis smoke less likely to cause cancer than tobacco smoke

According to a leading U.S. expert, cannabis smoke is less likely to cause cancer than tobacco smoke.

18 Oct 2005

Discovery could lead to tests for the clinic or battlefield to diagnose ailments with just a few drops of blood

A way to detect fragments of broken brain cells that leak into the bloodstream may help doctors more quickly and precisely treat people with severe head injuries or brain diseases, say researchers at the University of Florida's McKnight Brain Institute.

17 Oct 2005

Cannabis boosts brain power in rats

Scientists now say that Cannabis, the third most popular recreational drug after alcohol and tobacco, could boost brain power.

17 Oct 2005

Cannabis boosts brain power in rats

Scientists now say that Cannabis, the third most popular recreational drug after alcohol and tobacco, could boost brain power.

16 Oct 2005

Aging may intensify and prolong feeling run down when common infections like the flu occur

A new study, done with mice and published in the Federation of the American Societies of Experimental Biology Journal, suggests that miscommunication between the immune system and brain may be to blame for extended sickness symptoms and other cognitive disorders in elderly people and animals with an infection.

11 Oct 2005

Tonsils reveal information that helps understand lupus

By snipping out and analyzing tiny samples of patients' tonsils, scientists have identified a key cellular checkpoint that is somehow bypassed in lupus patients, where harmful immune cells that normally are squelched by the body are mistakenly granted access.

9 Oct 2005

Discovery of molecular roots of asthma, arthritis, and multiple sclerosis

The molecular roots of inflammatory and autoimmune diseases such as asthma, arthritis, and multiple sclerosis (MS) have been discovered by a team of researchers led by The University of Texas M. D. Anderson Cancer Center. They say their findings may point to ways to effectively treat these diseases - if not stop them before they start.

4 Oct 2005

Discovery has implications for research on restoring mobility to people who have lost motor functions due to spinal cord injury

Yale School of Medicine researchers report in Science this week genetic evidence for the hypothesis that myelination, or formation of a protective sheath around a nerve fiber, consolidates neural circuitry by suppressing plasticity in the mature brain.

3 Oct 2005

Greasing the gears that drive the interferon signal

Interferon -- a critical protein that mediates the body's defense against a wide variety of infectious agents and tumors -- may soon have greater therapeutic value as the result of a new study by researchers at Washington University School of Medicine in St. Louis.

3 Oct 2005

Discovery of molecule that causes transverse myelitis

Hopkins researchers have discovered a single molecule that is a cause of an autoimmune disease in the central nervous system, called transverse myelitis (TM), that is related to multiple sclerosis.

26 Sep 2005

CytRx granted "Fast Track" designation for ALS drug

CytRx Corporation today announced that the U.S. Food and Drug Administration (FDA) has granted "Fast Track" designation for the company's leading drug candidate arimoclomol for the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).

26 Sep 2005

Aquaporin-4 is the first specific molecule to be defined as a target for the autoimmune response in any form of MS

Researchers have identified a molecular suspect in a disorder similar to multiple sclerosis (MS) that attacks the optic nerve and spinal cord, according to a report presented at the 130th annual meeting of the American Neurological Association in San Diego. The protein, called aquaporin-4, is a channel protein that allows water to move in and out of cells.

26 Sep 2005

Sclerosis News and Research

Tryptophan metabolites play an important role in the immune system

Exercise is good for multiple sclerosis, but it must be done correctly

Withdrawn MS drug works for Crohn's sufferers

Gene involved in B-cell development might play a role in multiple sclerosis

Trigger discovered that causes stem cells embryos to start developing into organs

Northwestern University move closer to new therapies for neurodegenerative disease

Intravenous lidocaine and oral derivatives relieve pain from damage to the nervous system

Blocking macrophage migration inhibitory factor molecule might prevent the progression of multiple sclerosis

Cannabis smoke less likely to cause cancer than tobacco smoke

Discovery could lead to tests for the clinic or battlefield to diagnose ailments with just a few drops of blood

Cannabis boosts brain power in rats

Cannabis boosts brain power in rats

Aging may intensify and prolong feeling run down when common infections like the flu occur

Tonsils reveal information that helps understand lupus

Discovery of molecular roots of asthma, arthritis, and multiple sclerosis

Discovery has implications for research on restoring mobility to people who have lost motor functions due to spinal cord injury

Greasing the gears that drive the interferon signal

Discovery of molecule that causes transverse myelitis

CytRx granted "Fast Track" designation for ALS drug

Aquaporin-4 is the first specific molecule to be defined as a target for the autoimmune response in any form of MS

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News